Laidlaw Capital Markets is pleased to have acted as Co-Manager on the $125,000,000 Follow-On Offering for Aldeyra Therapeutics.
Laidlaw Capital Markets is pleased to Co-Manage Aldeyra Therapeutics $125,000,000 financing alongside Jefferies and SVB Leerink. Over $300 million raised together since 2014, helping fuel Aldeyra’s excellent execution in developing its pipeline and delivering results Read More...
Laidlaw Wealth Management Boosts Investment Offering With Green Harvest Deal
Laidlaw Wealth Management Boosts Investment Offering With Green Harvest Deal December 12, 2019 12:21 PM Eastern Standard Time NEW YORK--(BUSINESS WIRE)--Laidlaw Wealth Management is pleased to announce that it is expanding its collaboration with Read More...
Laidlaw served as Co-Manager on the $34.5mm Affimed (AFMD) Follow-On Offering
Laidlaw Capital Markets is pleased to announce today's pricing of Affimed (AFMD). Laidlaw served as Co-Manager, alongside Jefferies and SVB Leerink, for the $34,500,000 Follow-On Offering. See full Press Release on Affimed Website Read More...
Laidlaw served as Financial Advisor on the $50mm Molecular Templates (MTEM) Follow-On Offering
Laidlaw Capital Markets is pleased to serve as Financial Advisor to Molecular Templates (MTEM) on the pricing of its $50,000,000 Follow-On Offering. This is Laidlaw's second transaction in the syndicate, helping raise more than Read More...
Laidlaw served as Financial Advisor on the $70mm Follow-On Offering for Arcturus Therapeutics (ARCT).
Laidlaw Capital Markets is pleased to announce today's pricing of a $70,000,000 Follow-On Offering for Arcturus Therapeutics (ARCT) around its Covid-19 vaccine and platform for other diseases. Laidlaw proudly served as Financial Advisor alongside Guggenheim, Read More...
A BRIGHTER FUTURE, with Laidlaw episode #6: Laidlaw Five with David Garrity (Session 4)
Podcast Series: A BRIGHTER FUTURE. Listen to our third session of the Laidlaw Five, our ongoing podcast series.
Stay In Touch